Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Assets Average (2016 - 2026)

Champions Oncology has reported Assets Average over the past 16 years, most recently at $29.3 million for Q1 2026.

  • Quarterly results put Assets Average at $29.3 million for Q1 2026, up 4.91% from a year ago — trailing twelve months through Jan 2026 was $29.3 million (up 4.91% YoY), and the annual figure for FY2025 was $29.2 million, down 3.25%.
  • Assets Average for Q1 2026 was $29.3 million at Champions Oncology, down from $30.4 million in the prior quarter.
  • Over the last five years, Assets Average for CSBR hit a ceiling of $36.3 million in Q1 2023 and a floor of $25.1 million in Q4 2024.
  • Median Assets Average over the past 5 years was $31.4 million (2022), compared with a mean of $30.8 million.
  • Biggest five-year swings in Assets Average: soared 30.48% in 2022 and later dropped 24.9% in 2024.
  • Champions Oncology's Assets Average stood at $35.4 million in 2022, then fell by 17.74% to $29.1 million in 2023, then decreased by 13.79% to $25.1 million in 2024, then grew by 21.0% to $30.4 million in 2025, then fell by 3.46% to $29.3 million in 2026.
  • The last three reported values for Assets Average were $29.3 million (Q1 2026), $30.4 million (Q4 2025), and $31.4 million (Q3 2025) per Business Quant data.